Rituximab Added to Conditioning Regimen Significantly Improves Erythroid Engraftment in Major Incompatible ABO-Group Hematopoietic Stem Cell Transplantation

Investigators evaluated the efficacy of pre-transplant infusion of rituximab in patients with ABO-incompatibility in improving red blood cell engraftment after HSC transplantation, measured by time to reach transfusion independence.